We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing

News   May 07, 2010

 
Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
 
 
Advertisement
 

RELATED ARTICLES

Common Genetic Variant Identified As Frequent Cause of Deafness

News

A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research.

READ MORE

How Uromodulin Helps Against Urinary Tract Infections

News

The exact process by which uromodulin prevents inflammation had never been understood. Now an interdisciplinary team, drawn from three research groups at ETH Zurich together with researchers from the University of Zurich and the Children's Hospital Zurich, has filled this knowledge gap.

READ MORE

Accelerated Discovery of Bioactive Components in Seaweed

News

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers at the GEOMAR Helmholtz Centre for Ocean Research Kiel have succeeded in discovering new, bioactive components of the Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE